The National Institute for Health and Care Excellence (NICE) has recommended cladribine (Mavenclad, Merck Serono) for adults in England with relapsing-remitting multiple sclerosis (RRMS). This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback